All In Biotech

Free tool

FAERS Monitor: Mysoline

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 009170 or its brand name (Mysoline, Primidone). Reports on generic versions are filed under their own applications.

Reports

10,264

Serious

6,711

65% of reports

Hospitalization

3,199

Death reported

884

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective845
  • fall673
  • fatigue650
  • tremor591
  • off label use509
  • dizziness508
  • diarrhoea506
  • nausea479
  • drug interaction410
  • headache407
  • somnolence392
  • dyspnoea368
  • asthenia365
  • weight decreased338
  • pain331

Reports by year received

View as table
YearReports
2004173
2005195
2006175
2007157
2008184
2009195
2010277
2011300
2012345
2013352
2014391
2015676
2016743
2017666
2018673
2019684
2020692
2021636
2022562
2023591
2024570
2025580
2026446

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,895 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
tremorSignal5917.36.83,232
drug interactionSignal4105.34.81,436
fallSignal6734.23.91,629
somnolenceSignal3924.03.6884
weight decreasedSignal3382.52.2301
dizzinessSignal5082.11.9294
asthenia3652.01.8182
fatigue6501.71.6199
diarrhoea5061.61.5119
dyspnoea3681.31.231
headache4071.31.234
drug ineffective8451.31.267
nausea4791.21.123
off label use5091.21.116
pain3311.11.03

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.